Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Biopharma’s 20 highest-paid CEOs of 2023, earning $20M+ pay packages
Last year
Pfizer CSO Mikael Dolsten to depart after 15 years leading drug giant's R&D
Last year
Apollomics plans to lay off staff, narrow focus for lung cancer trial
Last year
R&D
Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot
Last year
R&D
Takeda to lay off more employees in Massachusetts
Last year
Pharma
Aerovate plans to lay off nearly all employees after trial failure
Last year
R&D
Pharma
Q&A: Vertex’s pain research chief on moving beyond opioids, AI and how pharma acquisitions thrive or fail
Last year
R&D
Ginkgo to cut at least 35% of staff in multi-year restructuring plan
Last year
Pharma
Biopharma leaders charting a path for the industry's LGBTQ+ community
Last year
Special
Lilly cracks down further on compounded tirzepatide as GLP-1 shortage starts to ease
Last year
Law
Stephen Squinto talks writing checks and next-gen obesity drugs as JP Morgan closes first $500M+ biotech fund
Last year
Financing
Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech
Last year
Peer Review
Barinthus Bio to lay off 25% of its workforce and focus on just two programs
Last year
R&D
Corrected: Life science company Agilent cuts over 180+ employees in California
Last year
Manufacturing
Teladoc names insurance executive as new CEO
Last year
Health Tech
Google's parent company Alphabet poaches Eli Lilly CFO; More changes at Exscientia
Last year
Peer Review
Former Sanofi R&D leader Frank Nestle to lead Deerfield’s growing drug discovery arm
Last year
R&D
Amarin names new CEO as Patrick Holt departs
Last year
BioNTech co-founder Özlem Türeci on ‘hip’ ADCs and the power of combo therapies
Last year
R&D
Cell/Gene Tx
Neurocrine CEO Kevin Gorman to retire after 32-year run; Bluebird picks up fifth CFO in three years
Last year
Peer Review
Ikena Oncology weighs ‘strategic options’ as it drops cancer asset, trims headcount to save cash
Last year
R&D
Joe Panetta to step down as Biocom California CEO
Last year
Takeda to lay off 640 workers in Massachusetts as part of multiyear overhaul
Last year
After 14 years calling partnering shots at Genentech/Roche, James Sabry is headed back into the biotech fray
Last year
Bioregnum
First page
Previous page
10
11
12
13
14
15
16
Next page
Last page